Clinical trial
Perioperative Use of Dexmedetomidine-esketamine Combination on Depression and Anxiety in Patients Undergoing Laparoscopic Ureteral Reconstruction: a Randomized Controlled Trial
NCT07753772 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Perioperative Use of Dexmedetomidine-esketamine Combination on Depression and Anxiety in Patients Undergoing Laparoscopic Ureteral Reconstruction: a Randomized Controlled Trial
- Lead sponsor
- Peking University First Hospital
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- August 31, 2026
- Completion date
- August 31, 2029
- Enrollment
- 658 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anxiety, depressive symptoms, dexmedetomidine, esketamine, ureteral stricture